Structural insights into the central complement component C3

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 3-10

  Janssen, Bert J C ^a   Gros, Piet ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

2 macroglobulin family; C3; Complement system; Innate immunity; Structure

Indexed keywords

COMPLEMENT COMPONENT C3;

ALPHA CHAIN; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DOWN REGULATION; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

BINDING SITES; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; HUMANS; PROTEIN STRUCTURE, TERTIARY;

EID: 33751034985     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.017     Document Type: Article

References (69)

1. Becherer J.D., Alsenz J., Esparza I., Hack C.E., and Lambris J.D. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B. Biochemistry 31 (1992) 1787-1794
2. Blandin S., and Levashina E.A. Thioester-containing proteins and insect immunity. Mol. Immunol. 40 (2004) 903-908
3. Bokisch V.A., Muller-Eberhard H.J., and Cochrane C.G. Isolation of a fragment (C3a). of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 129 (1969) 1109-1130
4. Bramham J., Thai C.T., Soares D.C., Uhrin D., Ogata R.T., and Barlow P.N. Functional insights from the structure of the multifunctional C345C domain of C5 of complement. J. Biol. Chem. 280 (2005) 10636-10645
5. Budd A., Blandin S., Levashina E.A., and Gibson T.J. Bacterial alpha2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome?. Genome Biol. 5 (2004) R38
6. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5 (2004) 981-986
7. Chu C.T., and Pizzo S.V. alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab. Invest. 71 (1994) 792-812
8. Clemenza L., and Isenman D.E. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165 (2000) 3839-3848
9. Daoudaki M.E., Becherer J.D., and Lambris J.D. A 34-amino acid peptide of the third component of complement mediates properdin binding. J. Immunol. 140 (1988) 1577-1580
10. Davis III A.E., and Harrison R.A. Structural characterization of factor I mediated cleavage of the third component of complement. Biochemistry 21 (1982) 5745-5749
11. Diefenbach R.J., and Isenman D.E. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2. J. Immunol. 154 (1995) 2303-2320
12. DiScipio R.G. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan. Biochem. J. 199 (1981) 485-496
13. Esparza I., Becherer J.D., Alsenz J., De la Hera A., Lao Z., Tsoukas C.D., and Lambris J.D. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Eur. J. Immunol. 21 (1991) 2829-2838
14. Fearon D.T., and Austen K.F. Properd: binding to C3b and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142 (1975) 856-863
15. Fishelson Z. Complement C3: a molecular mosaic of binding sites. Mol. Immunol. 28 (1991) 545-552
16. Gilbert H.E., Eaton J.T., Hannan J.P., Holers V.M., and Perkins S.J. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. J. Mol. Biol. 346 (2005) 859-873
17. Hannan J.P., Young K.A., Guthridge J.M., Asokan R., Szakonyi G., Chen X.S., and Holers V.M. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. J. Mol. Biol. 346 (2005) 845-858
18. Harrison R.A., and Lachmann P.J. Novel cleavage products of the third component of human complement. Mol. Immunol. 17 (1980) 219-228
19. Helmy K.Y., Katschke Jr. K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., and van Lookeren Campagne M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124 (2006) 915-927
20. Herbert A.P., Uhrin D., Lyon M., Pangburn M.K., and Barlow P.N. Disease-associated sequence variations congregate in a polyanion-recognition patch on human factor H revealed in 3D structure. J Biol Chem. 281 (2006) 16512-16520
21. Hourcade D.E. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J. Biol. Chem. 281 (2006) 2128-2132
22. Huber R., Scholze H., Paques E.P., and Deisenhofer J. Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z. Physiol. Chem. 361 (1980) 1389-1399
23. Inal J.M., and Schifferli J.A. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2. J. Immunol. 168 (2002) 5213-5221
24. Isenman D.E., Kells D.I., Cooper N.R., Muller-Eberhard H.J., and Pangburn M.K. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 20 (1981) 4458-4467
25. Janssen B.J., and Gros P. Conformational Complexity of Complement Component C3. Adv. Exp. Med. Biol. 586 (2006) 291-312
26. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., and Gros P. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437 (2005) 505-511
27. Jenner L., Husted L., Thirup S., Sottrup-Jensen L., and Nyborg J. Crystal structure of the receptor-binding domain of alpha 2-macroglobulin. Structure 6 (1998) 595-604
28. Jokiranta T.S., Jaakola V.P., Lehtinen M.J., Parepalo M., Meri S., and Goldman A. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO. J. 25 (2006) 1784-1794
29. Kalli K.R., Ahearn J.M., and Fearon D.T. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J. Immunol. 147 (1991) 590-594
30. Kamata T., Wright R., and Takada Y. Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J. Biol. Chem. 270 (1995) 12531-12535
31. Kirkitadze M.D., and Barlow P.N. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 180 (2001) 146-161
32. Kolln J., Bredehorst R., and Spillner E. Engineering of human complement component C3 for catalytic inhibition of complement. Immunol. Lett. 98 (2005) 49-56
33. Kolln J., Spillner E., Andra J., Klensang K., and Bredehorst R. Complement inactivation by recombinant human C3 derivatives. J. Immunol. 173 (2004) 5540-5545
34. Lachmann P.J., Pangburn M.K., and Oldroyd R.G. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies. J. Exp. Med. 156 (1982) 205-216
35. Lagueux M., Perrodou E., Levashina E.A., Capovilla M., and Hoffmann J.A. Constitutive expression of a complement-like protein in toll and JAK gain-of-function mutants of Drosophila. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11427-11432
36. Lambris J.D. The multifunctional role of C3, the third component of complement. Immunol. Today 9 (1988) 387-393
37. Lambris J.D., Avila D., Becherer J.D., and Muller-Eberhard H.J. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. J. Biol. Chem. 263 (1988) 12147-12150
38. Lambris J.D., Ganu V.S., Hirani S., and Muller-Eberhard H.J. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 4235-4239
39. Lambris J.D., Lao Z., Oglesby T.J., Atkinson J.P., Hack C.E., and Becherer J.D. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156 (1996) 4821-4832
40. Lambris J.D., Sahu A., and wetsel R.A. The chemistry and biology of C3, C4 and C5. In: Volanakis J.E., and Frank M.M. (Eds). The Human Complement System in Health and Disease (1998), Marcel Decker, New York 83-118
41. Law S.K., and Dodds A.W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 6 (1997) 263-274
42. Law S.K., Lichtenberg N.A., and Levine R.P. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J. Immunol. 123 (1979) 1388-1394
43. Li Y., and Zhang L. The fourth blade within the beta-propeller is involved specifically in C3bi recognition by integrin alpha M beta 2. J. Biol. Chem. 278 (2003) 34395-34402
44. Lowell C.A., Klickstein L.B., Carter R.H., Mitchell J.A., Fearon D.T., and Ahearn J.M. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170 (1989) 1931-1946
45. McGuire S.L., and Bajt M.L. Distinct ligand binding sites in the I domain of integrin alpha M beta 2 that differentially affect a divalent cation-dependent conformation. J. Biol. Chem. 270 (1995) 25866-25871
46. Medicus R.G., Melamed J., and Arnaout M.A. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules. Eur. J. Immunol. 13 (1983) 465-470
47. Molina H., Perkins S.J., Guthridge J., Gorka J., Kinoshita T., and Holers V.M. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. J. Immunol. 154 (1995) 5426-5435
48. Morikis D., and Lambris J.D. The electrostatic nature of C3d-complement receptor 2 association. J. Immunol. 172 (2004) 7537-7547
49. Muller-Eberhard H.J., and Gotze O. C3 proactivator convertase and its mode of action. J. Exp. Med 135 (1972) 1003-1008
50. Nagar B., Jones R.G., Diefenbach R.J., Isenman D.E., and Rini J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280 (1998) 1277-1281
51. O'Keefe M.C., Caporale L.H., and Vogel C.W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 263 (1988) 12690-12697
52. Oran A.E., and Isenman D.E. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274 (1999) 5120-5130
53. Pangburn M.K., Schreiber R.D., and Muller-Eberhard H.J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146 (1977) 257-270
54. Patthy L. Genome evolution and the evolution of exon-shuffling-a review. Gene 238 (1999) 103-114
55. Prota A.E., Sage D.R., Stehle T., and Fingeroth J.D. The crystal structure of human CD21: implications for Epstein-Barr virus and C3d binding. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10641-106416
56. Ross G.D., Lambris J.D., Cain J.A., and Newman S.L. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs. CR1 cofactor activity. J. Immunol. 129 (1982) 2051-2060
57. Sarrias M.R., Franchini S., Canziani G., Argyropoulos E., Moore W.T., Sahu A., and Lambris J.D. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167 (2001) 1490-1499
58. Seya T., Turner J.R., and Atkinson J.P. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163 (1986) 837-855
59. Sun Z., Reid K.B., and Perkins S.J. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modeling. J. Mol. Biol. 343 (2004) 1327-1343
60. Sunyer J.O., Zarkadis I.K., and Lambris J.D. Complement diversity: a mechanism for generating immune diversity?. Immunol. Today 19 (1998) 519-523
61. Szakonyi G., Guthridge J.M., Li D., Young K., Holers V.M., and Chen X.S. Structure of complement receptor 2 in complex with its C3d ligand. Science 292 (2001) 1725-1728
62. Taniguchi-Sidle A., and Isenman D.E. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain. J. Immunol. 153 (1994) 5285-5302
63. Ueda T., Rieu P., Brayer J., and Arnaout M.A. Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18). Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10680-10684
64. van den Elsen J.M., Martin A., Wong V., Clemenza L., Rose D.R., and Isenman D.E. X-ray crystal structure of the C4d fragment of human complement component C4. J. Mol. Biol. 322 (2002) 1103-1115
65. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
66. Weiler J.M., Daha M.R., Austen K.F., and Fearon D.T. Control of the amplification convertase of complement by the plasma protein beta1H. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 3268-3272
67. Xiong Y.M., and Zhang L. Structure-function of the putative I-domain within the integrin beta 2 subunit. J. Biol. Chem. 276 (2001) 19340-19349
68. Zanotti G., Bassetto A., Battistutta R., Folli C., Arcidiaco P., Stoppini M., and Berni R. Structure at 1.44 A resolution of an N-terminally truncated form of the rat serum complement C3d fragment. Biochim. Biophys. Acta 1478 (2000) 232-238
69. Zuiderweg E.R., Nettesheim D.G., Mollison K.W., and Carter G.W. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochemistry 28 (1989) 172-185